Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Jefferies Downgrades Applied Molecular to Hold

Jefferies Downgrades Applied Molecular to Hold

Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.

Tesla’s ‘Peak China Dependency’ Could Be Over Within A Year, Analyst Says: Here’s Why

By Shanthi Rexaline

September 21, 8:07 AM

The Elon Musk-led electric vehicle giant Tesla Inc. (NASDAQ: TSLA) has been heavily reliant on China, both from the supply and demand perspective.

TSLA

Analyst Ratings

Unveiling 5 Analyst Insights On Eaton Corp

By Benzinga Insights

December 19, 10:00 AM

Explore what analysts are saying about Eaton Corp (NYSE:ETN) based on recent ratings: Bullish Somewhat Bullish Indifferent Somewhat…

ETN

inTest Q4 Adj EPS $0.34 Beats $0.32 Estimate, Sales $32.41M Beat $31.45M Estimate

By Benzinga Newsdesk

March 3, 7:31 AM

inTest (AMEX:INTT) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.32 by 6.25 percent. This is a 385.71 percent increase over earnings of $0.07 per share from the same

INTT

Walgreens Boots Alliance Posts Lower Q4 Profits On Falling COVID-19 Vaccination, Reaffirms Annual Guidance

By Vandana Singh

March 28, 8:56 AM

Walgreens Boots Alliance Inc’s (NASDAQ:WBA) Q2 FY23 sales increased 3.3% Y/Y to $34.9 billion, up 4.5% on a constant currency…

WBA

Jefferies Downgrades Applied Molecular to Hold

Related Posts

Tesla’s ‘Peak China Dependency’ Could Be Over Within A Year, Analyst Says: Here’s Why

Unveiling 5 Analyst Insights On Eaton Corp

inTest Q4 Adj EPS $0.34 Beats $0.32 Estimate, Sales $32.41M Beat $31.45M Estimate

Walgreens Boots Alliance Posts Lower Q4 Profits On Falling COVID-19 Vaccination, Reaffirms Annual Guidance